Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cassia fistula syrup is a herbal medicinal product derived from the fruit pulp of the *Cassia fistula* L. tree, commonly known as the golden shower tree. It is a staple of traditional Persian Medicine (where it is known as Foloos) and Ayurvedic medicine, primarily indicated for the treatment of chronic and functional constipation. The syrup's therapeutic effect is attributed to its high content of anthraquinone glycosides, such as sennosides and rhein. Upon ingestion, these compounds are metabolized by colonic microflora into active forms that stimulate the myenteric plexus, thereby increasing intestinal motility and peristalsis. Additionally, they inhibit water reabsorption by modulating aquaporin-3 expression and promote the secretion of electrolytes and fluid into the bowel lumen. Clinical trials have demonstrated its efficacy and safety profile in sensitive populations, including children and patients with chronic kidney disease, often showing non-inferiority to osmotic laxatives like lactulose.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cassia fistula syrup.